Harvard Apparatus Regenerative Technology, Inc. (HRGN) Return on equity 2016–2025
Harvard Apparatus Regenerative Technology, Inc. (HRGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-649.9%FY2025 · since FY2016: -652.7% → -649.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -649.9% | -409.9 pp |
| FY2024 | -240.0% | +308.1 pp |
| FY2023 | -548.1% | — |
| FY2020 | -432.4% | +332.7 pp |
| FY2019 | -765.1% | -383.1 pp |
| FY2018 | -382.0% | -33.9 pp |
| FY2017 | -348.1% | +304.6 pp |
| FY2016 | -652.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice